Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NeuroSigma Inc.
DescriptionTrigeminal nerve stimulation utilizing subcutaneous electrodes and an implantable pulse generator
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Electromagnetic
Latest Stage of DevelopmentPhase II
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today